Zacks Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,130
| Closed | -$208K | – | 671 |
|
|
2021
Q2 | $208K | Buy |
+1,130
| New | +$208K | ﹤0.01% | 560 |
|
|
2015
Q2 | – | Sell |
-7,138
| Closed | -$1.24M | – | 753 |
|
|
2015
Q1 | $1.24M | Buy |
7,138
+3,473
| +95% | +$602K | 0.04% | 250 |
|
|
2014
Q4 | $678K | Sell |
3,665
-129
| -3% | -$23.9K | 0.02% | 341 |
|
|
2014
Q3 | $629K | Sell |
3,794
-4,683
| -55% | -$776K | 0.02% | 351 |
|
|
2014
Q2 | $1.33M | Buy |
8,477
+1,808
| +27% | +$283K | 0.05% | 213 |
|
|
2014
Q1 | $1.02M | Buy |
6,669
+3,320
| +99% | +$505K | 0.04% | 248 |
|
|
2013
Q4 | $445K | Buy |
3,349
+515
| +18% | +$68.4K | 0.02% | 442 |
|
|
2013
Q3 | $329K | Buy |
2,834
+611
| +27% | +$70.9K | 0.01% | 488 |
|
|
2013
Q2 | $205K | Buy |
+2,223
| New | +$205K | 0.01% | 568 |
|